Apparatus physiotherapy in the treatment of rheumatic diseases

Karateev D.E.; Makevnina A.V.; Luchikhina E.L.; Tangieva A.R.

doi:https://doi.org/10.17116/kurort20219802131

Karateev D.E.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Makevnina A.V.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Luchikhina E.L.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Tangieva A.R.

Moscow Regional Research and Clinical Institute (MONIKI)

Apparatus physiotherapy in the treatment of rheumatic diseases

Authors:

Karateev D.E., Makevnina A.V., Luchikhina E.L., Tangieva A.R.

More about the authors

Journal: Problems of Balneology, Physiotherapy and Exercise Therapy. 2021;98(2): 31‑38

DOI: 10.17116/kurort20219802131

Read: 3173 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Karateev DE, Makevnina AV, Luchikhina EL, Tangieva AR. Apparatus physiotherapy in the treatment of rheumatic diseases. Problems of Balneology, Physiotherapy and Exercise Therapy. 2021;98(2):31‑38. (In Russ.)
https://doi.org/10.17116/kurort20219802131

Подписка 2026 Вопросы курортологии, физиотерапии и лечебной физической культуры (Problems of Balneology, Physiotherapy and Exercise Therapy)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the efficiency and safety of the ALMAG + magnetic therapy device in the treatment of osteoarthritis of the knee joints».

MATERIAL AND METHODS

The article presents preliminary data of a double-blind, placebo-controlled study «Evaluation of the efficacy and safety of the ALMAG + magnetic therapy device in the treatment of osteoarthritis of the knee joints». The study includes 70 patients (25 men, 45 women) of which 34 (48.6%) are patients with primary osteoarthritis (OA) of the knee joints (OAKS) and 36 (51.4%) are with secondary knee OA (on the background of immunoinflammatory rheumatic diseases). The patients were randomely divided into 2 groups: the main group (active devices) with 34 (48.6%) patients and the control group (placebo devices) — 36 (51.4%) patients. Patients of the main and control groups were comparable in all main parameters. During the study, the patients underwent 3 courses of treatment with the ALMAG + apparatus or with a placebo apparatus during the year. The preliminary analysis includes data on 58 patients who underwent at least 2 courses of therapy (28 patients from the main group and 30 from the control group).

RESULTS

Pain at rest decreased in the main group by 4.0±2.9 mm, in the control group — by 1.07±2.21 mm (p=0.420), after the second course — by 5.13±3.4 and 1.81±2.19 mm (p=0.406), respectively. In the main group, the total WOMAC index decreased after the 1st course of physiotherapy from 24.0±14.9 to 20.25±14.31 mm (p=0.038), after the 2nd course it slightly increased — to 22.96±14.8 mm (p=0.314), in the control group the WOMAC index did not change statistically significantly: it decreased after the 1st course from 26.3±21.9 to 24.6±20.83 mm (p=0.112), after the 2nd course it increased to 27.04±21.9 mm (p=0.088).

CONCLUSION

Thus, the use of the ALMAG + apparatus at home contributed to a decrease in pain at rest and a significant decrease in the WOMAC index in patients with primary and secondary OA of the knee joints. Pulsed magnetotherapy did not cause adverse events or exacerbation of immunoinflammatory diseases.

Keywords:

rheumatic diseases

pulsed magnetic field

magneto-therapy

rehabilitation of rheumatic diseases

apparatus physiotherapy

non-drug therapy

Authors:

Karateev D.E.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Makevnina A.V.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Luchikhina E.L.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Tangieva A.R.

Moscow Regional Research and Clinical Institute (MONIKI)

Received:

02.03.2021

Accepted:

07.03.2021

Close metadata

References:

Rossijskie klinicheskie rekomendacii. Revmatologiya. Pod red. Nasonova EL. M.: GEOTAR-Media; 2020. (In Russ.).
Abramoff B, Caldera FE. Osteoarthritis: Pathology, Diagnosis, and Treatment Options. Med Clin North Am. 2020;104(2):293-311. https://doi.org/10.1016/j.mcna.2019.10.007
Litwic A, Edwards MH, Dennison EM, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-199. https://doi.org/10.1093/bmb/lds038
https://doi.org/10.14412/1995-4484-2018-416-422 https://doi.org/10.14412/1995-4484-2018-416-422
Seed S, Dunican K, Lynch A. Osteoarthritis: a review of treatment options. Geriatrics. 2009;64(10):20-29.
Karateev DE, Luchikhina EL. Drug Therapy of Pain in Patients with Arthritis. Effective Pharmacotherapy. 2018;33:26-38. (In Russ.).
Migliore A, Gigliucci G, Alekseeva L, Avasthi S, Bannuru RR, Chevalier X, Conrozier T, Crimaldi S, Damjanov N, de Campos GC, Diracoglu D, Herrero-Beaumont G, Iolascon G, Ionescu R, Isailovic N, Jerosch J, Lains J, Maheu E, Makri S, Martusevich N, Matucci Cerinc M, Micu M, Pavelka K, Petrella RJ, Tarantino U, Raman R. Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements. Ther Adv Musculoskelet Dis. 2019;11:1759720X19893800. https://doi.org/10.1177/1759720X19893800
van den Bosch MHJ. Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease? Clin Exp Immunol. 2019;195(2):153-166. https://doi.org/10.1111/cei.13237
Balabanova RM. A novel approach to treating osteoarthrosis as a chronic inflammatory disease. Modern Rheumatology Journal. 2013;7(2):95-98. (In Russ.).
Balabanova RM. Role of immune inflammation in the pathogenesis of osteoarthrosis and possibilities of correction of immune impairments. Modern Rheumatology Journal. 2011;5(4):74-78. (In Russ.).
Balabanova RM. Role of interleukin-1 in osteoarthrosis and possibilities of its arrest. Modern Rheumatology Journal. 2011;5(1):58-62. (In Russ.).
Karateev DE. Modern Therapy of Osteoarthritis. Effective Farmacotherapy. 2020;16(16):36-46. (In Russ.). https://doi.org/10.33978/2307-3586-2020-16-16-36-46
Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16-21. https://doi.org/10.1016/j.joca.2012.11.012
Karateev DE, Luchihina EL, Osnovina IP, Makevnina AV. Rol’ reabilitacii i apparatnoj fizioterapii v strategii lecheniya revmaticheskih zabolevanij. Voprosy kurortologii, fizioterapii i lechebnoj fizicheskoj kul’tury. 2020;97(5):92-98. (In Russ.). https://doi.org/10.17116/kurort20209705192
Karateev AE. Skeletno-myshechnaya bol’: vydelenie klinicheskih fenotipov i racional’nyj podhod k lecheniyu. Al’manah klinicheskoj mediciny. 2019;47(5):445-453. (In Russ.). https://doi.org/10.18786/2072-0505-2019-47-042
Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, Blanco FJ, Espinosa R, Haugen IK, Lin J, Mandl LA, Moilanen E, Nakamura N, Snyder-Mackler L, Trojian T, Underwood M, McAlindon TE. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-1589. https://doi.org/10.1016/j.joca.2019.06.011
Kloppenburg M, Kroon FP, Blanco FJ, Doherty M, Dziedzic KS, Greibrokk E, Haugen IK, Herrero-Beaumont G, Jonsson H, Kjeken I, Maheu E, Ramonda R, Ritt MJ, Smeets W, Smolen JS, Stamm TA, Szekanecz Z, Wittoek R, Carmona L. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019;78(1):16-24. https://doi.org/10.1136/annrheumdis-2018-213826
Bruyère O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM, Al-Daghri NM, Herrero-Beaumont G, Martel-Pelletier J, Pelletier JP, Rannou F, Rizzoli R, Roth R, Uebelhart D, Cooper C, Reginster JY. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337-350. https://doi.org/10.1016/j.semarthrit.2019.04.008
Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162. https://doi.org/10.1002/acr.24131
Zhang Z, Huang C, Jiang Q, Zheng Y, Liu Y, Liu S, Chen Y, Mei Y, Ding C, Chen M, Gu X, Xing D, Gao M, He L, Ye Z, Wu L, Xu J, Yang P, Zhang X, Zhang Y, Chen J, Lin J, Zhao L, Li M, Yang W, Zhou Y, Jiang Q, Chu CQ, Chen Y, Zhang W, Tsai WC, Lei G, He D, Liu W, Fang Y, Wu D, Lin J, Wei CC, Lin HY, Zeng X. Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition). Ann Transl Med. 2020;8(19):1213. https://doi.org/10.21037/atm-20-4665
Agafonov BV, Sekirin AB, Smirnova SN, Topchij NV, Gorenkov RV, Larinskij NE, Sushinskij VE, Ivanickij LV. Ispol'zovanie magnitoterapii i nekotoryh drugih lechebnyh fizicheskih faktorov v obshchej vrachebnoj praktike (semejnoj medicine). Posobie dlya vrachej. Moskva: MONIKI; 2019.
Elshiwi AM, Hamada HA, Mosaad D, Ragab IMA, Koura GM, Alrawaili SM. Effect of pulsed electromagnetic field on nonspecific low back pain patients: a randomized controlled trial. Braz J Phys Ther. 2019;23(3):244-249. https://doi.org/10.1016/j.bjpt.2018.08.004
Bagnato G, Miceli G, Marino N, Sciortino D, Bagnato GF Pulsed electromagnetic fields in knee osteoarthritis: a double blind, placebo-controlled, randomized clinical trial. Rheumatology. 2016;55(4):755-762. https://doi.org/10.1093/rheumatology/kev426
Wu Z, Ding X, Lei G, Zeng C, Wei J, Li J, Li H, Yang T, Cui Y, Xiong Y, Wang Y, Xie D. Efficacy and safety of the pulsed electromagnetic field in osteoarthritis: a meta-analysis. BMJ Open. 2018;8(12):e022879. https://doi.org/10.1136/bmjopen-2018-022879
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039-1049. https://doi.org/10.1002/art.1780290816
Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494-502. https://doi.org/10.1136/ard.16.4.494
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-1840.
McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001;45(5):453-461. https://doi.org/10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w "> 3.0.co;2-w" target="_blank">https://doi.org/10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w
Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987;65:85-89. https://doi.org/10.3109/03009748709102182.
Karateev AE, Pogozheva EYu, Suhareva ML, Lila AM, Ivanov AV. Ocenka effektivnosti i bezopasnosti magnitoterapii pri osteoartrite. Rezul’taty mnogocentrovogo slepogo placebo-kontroliruemogo issledovaniya KOSMO (klinicheskaya ocenka sovremennoj magnitoterapii pri osteoartrite). Nauchno-prakticheskaya revmatologiya. 2020;58(1):55-61. https://doi.org/10.14412/1995-4484-2020-55-61
Karateev D, Makevnina A, Tangieva A, Luchikhina E, Hamhoeva H. Double-blind placebo-controlled trial of pulsed electromagnetic field therapy in knee osteoarthritis (preliminary results). Ann Rheum Dis. 2020;79(suppl. 1):1918, https://doi.org/10.1136/annrheumdis-2020-eular.6396